Rapid Micro Biosystems, Inc. RPID
Biotechnology: Laboratory Analytical Instruments · IPO 2021 · data as of November 13, 2026
Rapid Micro Biosystems, Inc. (RPID) is a industrial company listed in the US with a market value of about $33M. In the twelve months to June 30, 2026 it had revenue of $35M and net income of -$51M, a net margin of -145.6%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 16% a year, a 5-year average ROIC of -41%.
About Rapid Micro Biosystems
Rapid Micro Biosystems is listed in the US and classified in biotechnology: laboratory analytical instruments, IPO year 2021. Revenue went from $16M in 2020 to $34M in 2025, growth of about 15.9% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 5% over three years (dilution for shareholders). It spends 41% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $35M | $34M | $28M | $23M | $17M | $23M | $16M |
| Net income | -$51M | -$47M | -$47M | -$52M | -$61M | -$74M | -$37M |
| Free cash flow | -$40M | -$32M | -$46M | -$47M | -$65M | -$58M | -$32M |
| EPS (diluted) | $-1.11 | $-1.05 | $-1.08 | $-1.22 | $-1.43 | $-3.94 | $-126.11 |
| Net margin | -145.6% | -140.3% | -167.2% | -233.0% | -354.9% | -316.5% | -230.6% |
| ROIC | — | -65.8% | -48.5% | -35.7% | -36.4% | -16.9% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Rapid Micro Biosystems pay a dividend?
Not currently.
Is Rapid Micro Biosystems a good stock to buy?
We do not give buy or sell advice. Rapid Micro Biosystems scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.